Rocket One (RKTO) Price to Book (2019 - 2026)
Rocket One's (RKTO) quarterly Price to Book came in at 2.83 in Q2 2026, up 77.89% year-over-year from 1.59 in Q2 2025, and down 13.95% quarter-over-quarter from 3.29 in Q1 2026.
Analysis
Rocket One (RKTO) Price to Book (2019 - 2026) Analysis & Trends
Rocket One has disclosed Price to Book across 8 years of filings, most recently posting 2.83 for Q2 2026.
- In Q2 2026, Price to Book rose 77.89% year-over-year to 2.83; the TTM figure through Jun 2026 stood at 2.83 (up 77.89% YoY), while the FY2025 annual figure was 2.5, up 260.17% from the prior year.
- Price to Book came in at 2.83 for Q2 2026 at Rocket One, down from 3.29 in the prior quarter.
- In the past five years, Price to Book ranged from a high of 52.61 in Q1 2022 to a low of 0.4 in Q1 2023.
- Average Price to Book over 5 years is 5.84, with a median of 1.22 recorded in 2025.
- Year-over-year, Price to Book slumped 99.24% in 2023 and soared 288.92% in 2025.
- Over 5 years, Price to Book stood at 1.66 in 2022, then slumped by 69.06% to 0.51 in 2023, then soared by 34.7% to 0.69 in 2024, then surged by 260.17% to 2.5 in 2025, then advanced by 13.21% to 2.83 in 2026.
- Per Business Quant data, the three most recent Price to Book figures were 2.83 in Q2 2026, 3.29 in Q1 2026, and 2.5 in Q4 2025.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Amgen | 211.73 Bn | 197.74 Bn | 7.24 Bn |
| 2 | Gilead Sciences | 180.92 Bn | 177.74 Bn | 6.22 Bn |
| 3 | Vertex Pharmaceuticals | 132.16 Bn | 124.30 Bn | 2.84 Bn |
| 4 | Regeneron Pharmaceuticals | 82.89 Bn | 74.90 Bn | 3.93 Bn |
| 5 | Argenx Se | 61.41 Bn | 56.23 Bn | 1.37 Bn |
| 6 | Moderna | 53.99 Bn | 48.85 Bn | 52.00 Mn |
| 7 | Alnylam Pharmaceuticals | 34.48 Bn | 31.18 Bn | 992.69 Mn |
| 8 | Biogen | 31.15 Bn | 29.86 Bn | 1.96 Bn |
| 9 | Roivant Sciences | 30.05 Bn | 30.05 Bn | 1.16 Mn |
| 10 | Rocket One | 13.86 Mn | 5.97 Mn | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 2.83 |
| Mar 31, 2026 | 3.29 |
| Dec 31, 2025 | 2.50 |
| Sep 30, 2025 | 2.98 |
| Jun 30, 2025 | 1.59 |
| Mar 31, 2025 | 1.14 |
| Dec 31, 2024 | 0.69 |
| Sep 30, 2024 | 0.77 |
| Jun 30, 2024 | 0.63 |
| Mar 31, 2024 | 0.79 |
| Dec 31, 2023 | 0.51 |
| Sep 30, 2023 | 0.47 |
| Jun 30, 2023 | 0.91 |
| Mar 31, 2023 | 0.40 |
| Dec 31, 2022 | 1.66 |
| Sep 30, 2022 | 1.30 |
| Jun 30, 2022 | 30.08 |
| Mar 31, 2022 | 52.61 |
| Dec 31, 2021 | 40.02 |
| Sep 30, 2021 | 53.44 |